Table 1 Demographic, clinical and laboratory data at the admission in ICU (T0)
|  | Standard nutrition (N = 15) | Specialized nutrition (N = 16) | p-value |
|---|---|---|---|
Sex (M: F) | 11: 4 | 13: 3 | 0.433 |
Age (Years) | 56 ± 22 | 51 ± 22 | 0.56 |
GCS | 7 [7, 8] | 7 [6.75–7.25] | 0.69 |
BMI (Kg/m2) | 25.3 ± 4.3 | 24.5 ± 3 | 0.56 |
mNUTRIC score | 6 [4–6.5] | 4 [3–5.25] | 0.34 |
APACHE II score | 20 [18–23] | 17.5 [13.75–23] | 0.28 |
SAPS II score | 53 [49–58.5] | 46.5 [40–59.25] | 0.22 |
Albumin (g/dl) | 3.48 ± 0.66 | 3.22 ± 1.1 | 0.94 |
Proteins (g/dl) | 5.41 ± 0.5 | 5.63 ± 1.2 | 0.48 |
White blood cells (10^3/mcl) | 13.5 ± 3.7 | 12 ± 4.7 | 0.57 |
Procalcitonin (ng/ml) | 0.5 ± 1 | 0.2 ± 0.6 | 0.31 |
Platelets (10^3/mcl) | 214.2 ± 70.2 | 196.37 ± 83.7 | 0.37 |
Platelet distribution width (fL) | 12.3 ± 1.8 | 13.6 ± 3.1 | 0.16 |
Mean platelet volume (fL) | 10.7 ± 0.8 | 11.1 ± 1.4 | 0.26 |
Plateletcrit (%) | 0.2 ± 0.006 | 0.2 ± 0.007 | 0.22 |
Creatinine (mg/dl) | 1.5 ± 1.8 | 1.6 ± 2 | 0.22 |
Vasopressor use, N(%) | 10 (67%) | 12 (75%) | 0.43 |
smokers,N(%) | 4 (26%) | 7 (43%) | 0.10 |
Marshall score | 2 [2, 3] | 2.5 [2, 3] | 0.59 |
Comorbidities | |||
Neurological | 5 (33%) | 3 (19%) | 0.19 |
Cardiovascular | 9 (60%) | 6 (37%) | 0.05 |
Diabetes | 2 (13%) | 0 (0%) | 0.10 |
Respiratory | 2 (13%) | 1 (6%) | 0.36 |
Empiric cephalosporin treatment at T7, N (%) | 7 (47%) | 5 (31%) | 0.19 |